Chapter 23: Opioid Analgesics and Antagonists

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

We have, well, a massive stack of papers on the desk today, but honestly, it all centers around one specific text.

Oh yeah, we are zeroing in.

We are.

We're looking at chapter 23 of Brenner and Stevens Pharmacology, the sixth edition.

And it is an absolute beast of a chapter.

It is.

And, you know, the topic is one that sits right at the intersection of, well, biological necessity and societal tragedy.

We are talking about opioid analgesics and antagonists.

Now, usually we might take a broad look at a topic, maybe pull in some news or culture, but looking at the source material today, I think we have a different mission.

I agree.

This reads like a battle plan for medical boards.

It absolutely is.

And that's exactly how we need to treat it.

If you're listening to this, you might be staring down and encouraging exam date, or, you know, maybe you're a clinician who realizes they've forgotten the actual biochemistry behind the prescription pad.

Our goal today is to go into what we call last minute lecture mode.

We aren't skimming.

We are going to deconstruct the physiology of pain, the molecular mechanics of these drugs, and the clinical nuances that separate a safe practitioner from a dangerous one.

And just to be super clear, we aren't talking about NSAIDs like ibuprofen today.

That's a whole other thing.

That's chapter 30.

We'll get there.

Exactly.

Today, we are strictly talking about the heavy hitters, the drugs that work in the central nervous system.

But before we can even talk about how to stop pain,

the text forces us to ask a question that feels philosophical but is actually physiological.

What is pain?

What is pain?

It's the oldest question in medicine, isn't it?

And Brenner and Stevens, they give us a definition that is deceptively simple.

They define pain as an unpleasant sensory and emotional experience.

That and is doing a lot of heavy lifting there.

It is everything.

It distinguishes between the signal and the suffering.

The sensory part is just data.

It's your nerves telling you, your hand is on a hot stove.

That's protective.

You need that.

You absolutely need it.

If you didn't have that, you'd burn your hand to a crisp.

But the emotional part, the misery, the anxiety, the fear, that is where the morbidity lies.

I see.

The text makes this distinction between pain as

like a symptom versus pain as a destructive force in itself.

It uses the phrase unbridled expression of pain.

Exactly.

When pain goes unchecked, it stops being a warning system and starts becoming a disease state all its own.

How so?

It drives up cortisol.

It stresses the heart.

It prevents healing.

When we talk about opioids, we are trying to sub you that link between the

tissue damage and that unbridled emotional destruction.

Okay.

Let's get into the wiring.

Section one of our outline is the physiology of pain.

Let's say I jam my toe or a patient has a kidney stone.

What is the actual route that signal tastes?

The text lays out a specific architecture for this.

Right.

And this is crucial for diagnosis.

It's not all one kind of pain.

They call them qualities of pain.

Yeah.

And they break it down into three buckets.

First up is somatic pain.

Think of this as body pain.

Like skin, muscle.

Skin, muscle, soft tissue.

It's localized.

If you cut your finger, you can point to exactly where it hurts.

Simple.

Okay.

Versus visceral pain.

Visceral pain is a whole different animal.

It comes from the thoracic or abdominal organs.

It's poorly localized.

You might feel a dull ache in your belly, but you can't pinpoint it with one finger.

And it does that weird thing.

Referred pain.

Exactly.

A key feature the text highlights is that visceral pain is often referred.

Referred pain is fascinating.

The classic example is the heart attack, right?

Feeling pain in the arm or the jaw.

It's the classic.

The brain gets confused because the sensory inputs from the heart and the sensory inputs from the arm, they enter the spinal cord at the same level.

Ah, so the wires get crossed.

See, the wires get crossed.

The brain just interprets the heart distress as arm pain.

It's a glitch in the mapping.

And then there's the third type, which is notoriously difficult to treat.

Neuropathic pain.

Yeah, this is pain caused by damage to the nerves themselves.

So not a signal about damage, but the signal sender is the damage.

Precisely.

It could be compression like a slip disc, inflammation, or metabolic damage like you see in diabetes.

The text lists examples like trigeminal neuralgia or fibromyalgia.

Patients often describe this differently.

It's not an ache, it's burning, shooting, or stinging.

Okay, let's visualize the ascending pathway.

This is the road from the injury site up to the conscious brain.

Let's use the hammer example.

I drop a hammer on my foot.

What is happening at the molecular level in my toe?

Okay, so boom, you've just activated nociceptors.

These are just free nerve endings that respond to noxious stimuli, that mechanical pressure, extreme heat, or chemicals that are released by the damaged cells.

Right.

Now this is a keyboard exam distinction that signal travels to the spinal cord on two very different types of railroads.

The A delta fibers and the C fibers.

I always, always struggle to keep these straight.

Okay, simple way to think of it.

Think of A delta as first class or the express train.

These fibers are myelinatives.

The insulation.

Myelin is insulation, yeah.

It makes the signal travel super fast.

A delta fibers carry that initial sharp stinging, where is the hammer pain?

It's the fast pain.

So A delta is the immediate owl reflex.

Right, but then a second or two later, you get that throbbing, burning, miserable ache that just hangs around.

That is the C fiber.

C fibers are unmyelinated.

They are slow.

They are the economy class train.

They carry the slow pain that lingers.

And both of these trains, the express and the local, they pull into the same station.

They do.

The dorsal horn of the spinal cord.

This is the first relay station.

This is where the peripheral nerve meets the central nervous system.

And they have to pass the message on.

They pass the baton.

They do that by releasing excitatory neurotransmitters, specifically substance P and glutamate.

Substance P always sounds like a placeholder name that scientists just forgot to change later.

It really does, doesn't it?

But you can think of it as substance pain.

It's basically a peptide that screams ouch to the next neuron in the chain.

Now, once that baton is passed in the spinal cord, the signal crosses over to the other side.

It decussates and shoots up to the brain via the spinothalamic tracts.

And the text splits this tract again, which I found fascinating.

It's not just one wire going up to the brain.

No, and this maps back perfectly to our definition of pain.

You have the neospinothalamic tract, neo, meaning new.

This one goes to the sensory cortex.

The thinking part of the brain.

The thinking part.

It tells you the pain is in the left big toe and it feels like a crushing sensation.

It's the GPS.

It gives you the location and the quality.

The sensory discriminative aspect, as the book said.

Precisely.

But then you have the paleospinothalamic tract, paleo, meaning old.

This is evolutionarily ancient.

This one doesn't go to the sensory cortex.

It goes to the limbic system.

The amygdala, the emotional centers.

That's the one.

This is the wire that tells you to cry or to get angry.

It's the wire that generates the suffering, the fear, the make it stop response.

And this is so crucial because opioids work beautifully on this motivational, effective component.

Ah, so that's the mechanism.

It is.

A patient on morphine might say, you know, I can still feel the pain.

I know it's there, but it just doesn't bother me anymore.

That's because you've dampened the paleospinothalamic input.

Even if the neospinothalamic might still be firing a bit.

That is a critical distinction for managing patient expectations.

We aren't always eliminating the sensation.

A lot of the time we're managing the emotional burden.

Exactly.

But the body isn't just a passive victim here, right?

We have our own built -in countermeasure.

We do.

The descending inhibitory pathway, or as the text calls it, the gate control system.

This is the body's braking system for pain.

Okay.

So let's walk through the anatomy of the brakes.

Where does it start?

It starts high up in the midbrain in a region called the periaqueductal gray or PAG.

The PAG.

The PAG is like the general commanding the defense.

It sends signals down to the medulla specifically to two places.

The nucleus raffia magnus and the locus coeruleus.

And these nuclei, they send fibers all the way back down to the spinal cord.

All the way back down.

They send fibers down to the dorsal horn right back to where that A delta and C fiber first came in.

To shut the gate.

To shut the gate.

And they do it by releasing inhibitory neurotransmitters, serotonin and norepinephrine.

Wait, hold on.

Serotonin and norepinephrine.

Usually we think of those as excitatory or, you know, related to mood and oppression in the brain.

Context is everything in neuroscience.

In the dorsal horn of the spinal cord, these chemicals are inhibitory.

They dampen the signal.

They basically tell the relay neuron, hey, ignore those incoming C fibers.

Don't send that message up to the brain.

This explains the mechanism of some of our non -opioid drugs, doesn't it?

I know the text mentions antidepressants later on for pain.

Bingo.

Tricyclic antidepressants.

SNRIs.

They increase serotonin and norepinephrine everywhere, including the spinal cord.

By doing that, they artificially strengthen this descending braking system.

That's why they work so well for chronic pain.

The text also uses a really common, relatable example to illustrate this gate control.

The rubbing the elbow phenomenon.

It's the classic physiological hack.

We've all done it.

You bang your elbow and your first instinct is to rub it vigorously.

Why?

Distraction.

It feels like that, but it's chemical.

Rubbing activates a beta fibers.

These are touch sensors, not pain sensors.

Okay.

When a beta fibers fire, they stimulate these little inhibitory interneurons in the spinal cord.

And those interneurons release enkephalin.

Enkephalin.

Sounds like it.

Like in the head.

It's an endogenous opioid.

It's your body's own natural painkiller.

So the touch signal tells the spinal cord to release its own morphine to shut the gate on the pain signal.

You are chemically hacking your own nervous system.

Which brings us perfectly to section two, endogenous opioids.

Because it turns out we didn't evolve these complex receptors just in case we stumbled upon a poppy field in Afghanistan.

Right.

The discovery of the morphine receptor implied the existence of some kind of internal morphine.

And scientists found them.

The text lists the three families of these endogenous peptides.

Enkephalins, beta endorphins, and dinorphins.

These are the body's own heavy artillery against pain.

They are.

And they bind to very specific receptors.

The text highlights three main ones you need to know.

Mu, delta, and kappa.

Let's break these down because clinically they are definitely not created equal.

The Mu receptor, it seems to be the main character of this entire story.

The Mu receptor is the celebrity.

It is responsible for most of the profound analgesia we get from drugs like morphine.

But as with most celebrities, it comes with a lot of baggage.

Mu activation is also responsible for the most dangerous side effect respiratory depression.

It's also the driver of physical dependence and the euphoria that drives addiction.

So it's a double -edged sword by its very design.

What about kappa?

Kappa is the dark horse receptor.

It provides some analgesia, sure.

But activation of kappa receptors often causes dysphoria, a sense of unease or dissatisfaction, and even psychotomimetic effects.

Like hallucinations.

Exactly.

It's not a clean pain relief.

So ideally for a perfect drug, we want something that hits Mu really well, but leaves kappa alone.

Generally, yes.

For pure analgesia, that's the goal.

Though we will talk about some mixed action drugs later that try to play both sides for safety reasons.

Okay, this is the part of the lecture where everyone needs to wake up and really focus.

The mechanism of action.

Figure 23 .1 in the text.

How does an opioid receptor actually turn off a neuron?

We aren't talking about magic.

We're talking about ions and enzymes.

This is high -yield physiology.

It's guaranteed to be on the exam.

So opioid receptors are G -protein coupled receptors.

Specifically, they are linked to the G -protein.

I for inhibitory.

Correct.

When morphine or any opioid binds to the Mo receptor, that G -protein kicks off a three -step cascade to shut the cell down.

Okay, step one.

Inhibition of adenylate cyclase.

This is an enzyme that normally produces something called camp -MP, cyclic AMP.

Which is like the energy currency for cell signaling.

Exactly.

The opioid shuts this factory down.

Less camp -E means the cell is less excitable.

It just lowers the metabolic hum of the whole neuron.

Okay, step two involves potassium.

This is crucial.

The receptor activation opens potassium channels.

Now, you got to remember your gradients from basic physiology.

Potassium is high inside the cell.

So if you open the door, potassium rushes out.

And potassium ions are positively charged.

So positive charge is leaving the cell.

Which makes the inside of the cell more negative.

Hyperpolarization.

Hyperpolarization, exactly.

A hyperpolarized cell is incredibly hard to fire.

You are essentially turning the volume knob from a five down to a nevic 10.

It becomes resistant to any incoming pain signals.

And the third step.

Closing calcium channels.

This happens at the presynaptic terminal, the very end of the nerve fiber that's releasing the pain signal.

Calcium is the key that unlocks the vesicles filled with neurotransmitters.

No calcium, no release.

No calcium can get in.

The neuron physically cannot release its substance P or its glutamate.

So let me just summarize this to make sure I have this mechanic locked down.

It's a triple threat.

One, you starve the cell of signaling energy by blocking camp -E.

Two, you hyperpolarize the membrane so it can't fire an action potential by letting potassium out.

And three, you physically block the release of the pain message by preventing calcium from getting in.

That is a comprehensive cellular shutdown.

You are silencing the sender on the presynaptic side and you are deafening the receiver on the postsynaptic side.

It's incredibly elegant in a ruthless sort of way.

Now let's zoom out.

Let's move to section three.

Pharmacologic effects.

When we flood the entire system with an exogenous opioid like morphine, we get a lot more than just pain relief.

The text has a laundry list in box 23 .2.

This list is basically the review of systems for an opioid user.

You have to know this stuff.

Let's start with the CNS.

Obviously, analgesia.

That's the goal.

But you also get changes in mood.

Euphoria, usually.

Usually euphoria, which is mediated by disinnovation of dopamine in the reward pathways of the brain.

But sometimes dysphoria.

And the text notes a really specific diagnostic sign in the eyes.

Meiosis.

Pinpoint pupils.

This is due to stimulation of the Edinger Westfall nucleus in the brainstem.

And here is a vital clinical pearl for you.

You do not develop tolerance to meiosis.

So it doesn't matter how long someone has been using.

It doesn't matter if the patient has been on heroin for 10 years.

If they are acutely intoxicated, their pupils will be pinpoints.

It is the most reliable physical sign of opioid intoxication.

What about the Gough reflex?

It's suppressed.

Opioids act on the cough center in the medulla.

That's why codeine is so commonly found in prescription cough syrup.

It just shuts down the urge to cough.

OK, moving down to the chest.

The cardiovascular system.

Why do people on morphine sometimes get itchy and red?

It seems like an allergic reaction.

It does.

But it's not a true allergy.

That's the histamine connection.

Morphine specifically causes mast cells to degranulate and just dump out histamine.

The histamine causes.

Vasodilation, which is the flushing, and pruritus, which is the itching.

That vasodilation can also lead to orthostatic hypotension.

You stand up too fast and get dizzy because your blood pressure drops.

Now the respiratory system, this is the killer.

It is.

This is what we're terrified of.

Opioids cause respiratory depression by acting directly on the brainstem respiratory centers.

Specifically, they reduce the sensitivity of those centers to carbon dioxide, to CO2.

Normally, if I hold my breath, CO2 builds up in my blood and my brain just screams,

breathe.

That's your hypercapnic drive.

It's a powerful primitive reflex.

Opioids blunt that.

The CO2 levels can rise to dangerous acidic levels and the brain just doesn't care.

The patient simply forgets to breathe.

Wow.

In a serious overdose, respiration can drop to three or four breaths per minute or zero.

And this leads to a very specific contraindication regarding head injuries.

I want to spend a moment here because it's a connect the dots logic that boards absolutely love to test.

It's a classic trap cushion.

Imagine a patient comes in from a car accident with a traumatic brain injury.

They likely have increased intracranial pressure or ICP.

They are also in a lot of pain.

So you think, I'll give them morphine.

OK, so you get the morphine.

First, it depresses respiration.

So CO2 starts to build up in the blood.

And here is the key physiological link.

CO2 is a potent cerebral vasodilator.

The blood vessels in the brain are exquisitely sensitive to it.

So the brain sees high CO2 and thinks, I'm suffocating.

I need more oxygen.

So it dilates the blood vessels in the brain to increase blood flow.

Precisely.

Which pumps more and more blood into an already squeezed, pressurized, and closed skull.

And you massively spike the intracranial pressure.

You spike the ICP, potentially causing brain herniation and death.

That is the chain of events.

That is why opioids are generally contraindicated, or at least used with extreme caution, in undiagnosed closed head injuries.

That is a chilling sequence of events.

OK, let's talk about the gut.

Constipation.

It's not just a side effect.

The book makes it sound like a guarantee.

It is the most common chronic complaint.

It is a guarantee.

Opioid receptors are dense in the enteric nervous system, the brain in your gut.

When you activate them, they increase the tone of the smooth muscle, but they decrease the propulsive contractions.

So the gut clamps down tight, but stops moving things forward.

Like a traffic jam.

It's a spastic paralysis of the gut.

And just like the pupils, here's another pearl, you do not develop tolerance to the constipation.

So it never gets better.

It never gets better.

If a patient is on chronic opioids, they need a bowel regimen.

Period.

No fiber alone.

That's like adding more cars to the traffic jam.

They need stimulants.

The text also mentions the biliary system.

Something about the sphincter of oddy.

Right.

Opioids can cause this little sphincter, which controls bile flow from the gallbladder to spasm and clamp down.

This can actually increase pressure in the bile duct.

So if a patient comes in with biliary colic, a gallbladder attack,

morphine might actually make the pain worse initially.

It theoretically could.

Yeah.

It can worsen the pressure that's causing the pain in the first place.

Finally, nausea.

Why do patients vomit?

Two reasons.

First is direct stimulation of the chemoreceptor trigger zone, the CTZ in the medulla.

But the text notes it's also related to vestibular sensitivity, the inner ear.

A balance system.

Right.

That's why nausea is often much worse in ambulatory patients, people who are walking around, compared to patients who are just lying still in bed.

The motion makes it worse.

Okay, that makes sense.

Let's move on to section four.

Tolerance and dependence.

These words get used interchangeably in the media all the time, but pharmacologically, they are very distinct entities.

We have to be precise here.

This is so important.

Tolerance is a pharmacologic concept.

It's a rightward shift in the dose -response curve.

Meaning?

It means that over time, you need a higher dose to achieve the same effect.

The text uses figure 23 .3 to show this graphically.

The whole curve just shifts to the right.

Why does the body do that?

Is it just getting used to it?

It's homeostatic pushback.

The cells see all this mu activation and say, whoa, this is way too much inhibition.

We can't function like this.

Yeah.

They start to fight back.

They down -regulate the receptors, literally pull them off the cell surface, so there are fewer targets for the drug to hit.

There are fewer locks for the keys.

Exactly.

They also up -regulate the CAMP pathway to try and counteract all the inhibition from the drug.

The cell adapts to this new drug -filled environment.

It does, and that is physical dependence.

The system has now adapted to a new normal where the drug is required just to maintain equilibrium.

If you stop the drug abruptly, you get withdrawal because now you have fewer receptors and a supercharged overactive CAMMP system with no drug to hold it back.

And withdrawal is?

It's essentially the exact opposite of the drug effect.

It is rebound hyperexcitability.

If the drug causes constipation, withdrawal causes explosive diarrhea.

If the drug causes sedation, withdrawal causes profound anxiety and insomnia.

If the drug causes pupil constriction, withdrawal causes massive pupil dilation.

It's the pendulum swinging way back the other way, hard.

Viciously hard.

And what about cross -tolerance?

This is the principle that if you are tolerant to one opioid, say heroin, you will be tolerant to others like methadone or morphine.

They all hit the same receptors.

And this is the basis for methadone treatment?

It's the entire basis.

You can substitute a safer, longer -acting opioid like methadone to prevent withdrawal without giving the patient that reinforcing high or rush.

That distinction is so vital for destigmatizing pain treatment and addiction medicine.

Okay, let's get into the medicine cabinet.

Section five,

specific strong opioid agonists, the prototypes.

We have to start with morphine, the gold standard, the one against which all other analgesics are measured.

Pharmacokinetically, so how the body handles it?

Morphine has a quirk regarding the liver.

It does.

It has a very high first pass metabolism, meaning the liver chews up a lot of it after you swallow it.

But the really interesting part is the metabolite.

The liver converts morphine into morphine -6 -glycuronide or M6G.

And M6G is?

It's actually more potent as an analgesic than morphine itself.

It's a supercharged version.

Which becomes a huge problem if your kidneys aren't working.

A huge problem.

M6G is cleared by the kidneys.

So in a patient with renal failure, M6G just accumulates and accumulates.

You can get profound sedation and respiratory depression from standard doses because the act of trash isn't being taken out.

Next on the list is fentanyl.

We hear about this constantly in the news, but medically it's a really unique and important tool.

Fentanyl is a synthetic opioid.

It is about 100 times more potent than morphine.

But its defining characteristic is its lipid solubility.

It loves fat.

Which allows it to cross biological membranes, like the skin or the blood -brain barrier, almost instantly.

That's exactly why we can use it in transdermal patches, like the durogesic patch.

It just soaks right through the skin over a few days.

It's also why it has such a rapid onset when used in anesthesia.

The text mentions some even more extreme derivatives like remafentanyl.

Remafentanyl is the anesthesiologist's dream drug.

It isn't metabolized by the liver or kidneys.

It's broken down by esterase enzymes that are just floating in the blood.

So its half -life must be incredibly short.

Minutes.

Three to four minutes.

You turn the IV drip off and the patient wakes up almost instantly.

It gives you incredible on -off control during surgery.

And carfentanyl.

The text refers to it as an elephant tranquilizer.

And that's what it is.

It is thousands of times more potent than morphine.

It's a veterinary drug.

It has no place in human medicine.

Then there's Meparidine or Demerol.

This feels like an old -school drug that's kind of falling out of favor.

It is, and for a very good reason.

Meparidine has a toxic metabolite called Normaparidine.

Not good.

Not good at all.

Unlike Meparidine, which is a sedative, Normaparidine is a CNS stimulant.

It accumulates and causes tremors, anxiety, muscle twitches, and even seizures.

So why would you ever use it?

It has a very small niche.

Unlike morphine, it doesn't cause as much spasm in the sphincter of oddy or the uterus.

So traditionally it was preferred for labor pain and for gallbladder attacks.

But because of that seizure risk, especially in elderly patients or patients with bad kidneys, it is strictly for short -term, acute use.

Days at most.

And we can't skip methadone.

Methadone is a fascinating compound.

It's a strong mu agonist, sure, but it also does other things like block NMDA receptors.

But it's most famous for treating addiction because of its pharmacokinetics.

Its duration.

It has a massive half -life and duration of action.

You can dose it just once a day.

It prevents withdrawal and cravings without giving that rapid rush of a drug like heroin.

But the text warns about its variable half -life.

It says it can be 15 hours in one person and 60 hours in another.

Which makes dosing really tricky, especially at the beginning.

If you increase the dose too fast, it accumulates what we call stacking.

And the patient can have a delayed overdose days after their last dose change.

It requires very careful management.

Let's slide down the potency scale.

Section 6.

Moderate and other opioid agonists.

We have to start with codeine.

Codeine is arguably the most misunderstood drug in this entire class.

Here is a secret you have to know.

Codeine itself is a very weak drug.

It has almost no affinity for the mu receptor.

So how does it work then?

It is a pro -drug.

It completely relies on the litter enzyme CYPT2D6 to metabolize it, to convert it into morphine.

So if you take a Tylenol hashtag 3, you are basically banking on your own liver to manufacture the active drug for you.

But genetic variability in that enzyme plays a huge role here.

A huge role.

About 10 % of Caucasians lack a functioning CYPT2D6 enzyme.

They are poor metabolizers.

You can give them buckets of codeine and they will get zero pain relief.

It's just a placebo with side effects for them.

And on the flip side of that coin.

The ultra -rapid metabolizers.

These people have multiple copies of the CYPT2D6 gene.

They convert codeine to morphine at lightning speed, getting a much higher dose than expected.

The text mentions a specific FDA black box warning about this regarding breastfeeding mothers.

Yes, and this is a nightmare scenario.

If a nursing mother is an ultra -rapid metabolizer, she takes a standard dose of codeine, her body converts it to unusually high levels of morphine in her blood, which then passes into the breast milk.

There have been tragic documented cases of infants dying from morphine overdoses because their mom was taking standard doses of codeine.

That is a sobering reminder that even mild opioids are not harmless.

Okay, tramadol.

This one is prescribed everywhere.

Tramadol is unique because it's kind of a dirty drug.

It hits multiple targets.

It is a weak moo agonist, yes, but its main other action is that it inhibits the reuptake of serotonin and norepinephrine.

So it acts like an antidepressant.

Exactly, which explains why it works so well for neuropathic pain, as we discussed with the descending pathway.

It strengthens the body's own braking system.

The text has a case study, the case of a painful pox, about a professor with shingles.

Right, shingles causes posopedic neuralgia, which is classic nerve damage pain.

And standard opioids often don't touch nerve pain very well.

But tramadol, by boosting that norepinephrine in the spinal cord, strengthens the braking system.

It attacks the pain from two different angles.

But because it messes with serotonin,

there are risks.

Definitely.

If the patient is already on SSRIs, you can precipitate serotonin syndrome, which is a medical emergency with high fever, rigidity, and seizures.

Also, tramadol itself lowers the seizure threshold.

It's not a drug to hand out like candy.

There is a new drug mentioned in the text, ulceradine.

What's the story here?

This is the concept of biased agonism, which you can see in Figure 23 .2.

The idea is to design a drug that activates the G -protein pathway, which gives you the analgesia, but avoids attracting a different protein called beta -arrestin.

And beta -arrestin is thought to be responsible for.

For the bad stuff.

Respiratory depression and constipation.

So, ulceradine tries to split the difference, get the pain relief without the dangerous side effects.

It's a specialized hospital drug.

Briefly, let's just touch on the antidiarrheals mentioned.

Right.

They are designed to stay in the gut and not cross the blood -brain barrier.

So, they paralyze the gut to stop diarrhea, but they don't get you high.

Okay.

This concept always confuses students.

Why on earth would you want a drug that stimulates one receptor and blocks another?

It's all about safety.

It's about creating a sealing effect.

The goal was to create an analgesic that couldn't kill you.

Enter buprenorphine.

Buprenorphine is the key player here.

It is a partial agonist at the MU receptor.

Partial means that even if you occupy 100 % of the receptors, you only get about, say, 50 % of the maximal effect.

So, there is a built -in sealing on the respiratory depression.

Exactly.

You can only depress your breathing so much before the drug's effect maxes out.

It's much, much harder, though not impossible, to have a fatal overdose on buprenorphine alone.

But it binds really tightly to the receptor.

Like superglue.

It has incredibly high affinity but low intrinsic activity.

It gets on the receptor and it does not let go.

Which makes it perfect for treating addiction.

Perfect.

It's the key ingredient in suboxone.

It sits on the receptor, blocks any incoming heroin from attaching, but it provides enough stimulation to prevent withdrawal symptoms.

However, there is a massive clinical trap here called precipitated withdrawal.

This is maybe the most important clinical point for this entire class of drugs.

You have to understand this.

Okay, so walk me through it.

I have a patient who is physically dependent on, say, heroin, a full agonist.

The heroin is sitting on their mu receptors, activating them at 100%.

Right.

They are high or at least not in withdrawal.

Now, you give them a dose of buprenorphine.

The buprenorphine has a higher affinity.

It's stronger.

It's stickier.

It rips the heroin molecules right off the receptor and takes their place.

But remember, buprenorphine only activates that receptor at 50%.

So the patient goes from 100 % receptor activation down to 50 % activation in one second.

That is a massive functional drop.

You have just induced an instant, explosive, violent withdrawal syndrome.

It is agonizing for the patient.

You must wait for the patient to be in mild withdrawal before starting buprenorphine to avoid this.

That's a critical, critical point.

Finally, section eight, the antagonists,

the rescue squad.

We have to talk about naloxone or Narcan.

Naloxone is a pure competitive antagonist.

It has a bulky chemical side chain.

It fits into the receptor, but it's the wrong shape to turn it on.

It literally just jams the lock so the opioid key can't get in.

So if a patient is overdosing, they're blue, they're not breathing, you give them naloxone.

What happens?

It kicks all the opioid molecules off the receptors almost instantly.

The patient wakes up often violently.

They might start vomiting.

They're confused and agitated.

But they're breathing.

It reverses everything immediately.

But there is a pharmacokinetic mismatch that the text highlights, and it's dangerous.

The half -life.

Naloxone is very short -acting.

It lasts maybe 60 to 90 minutes.

But a drug like morphine lasts four hours.

Methadone can last 24 hours or more.

So you revive the patient.

They seem fine.

You turn your back and walk away.

And an hour later, the naloxone wears off, but the opioid molecules are still floating around in the patient's system.

They reattach to the now unprotected receptors, and the patient slips right back into a coma and dies.

That's renarcotization.

It is.

You often need repeated doses of naloxone, or even a continuous IV drip to outlast the opioid.

One shot is often not enough.

Then we have these newer drugs, the peripheral antagonists like naloxagol.

These are just brilliant pieces of chemistry.

They really are.

They took a naloxone -like molecule, and they attached a big, peg -chain polyethylene glycol to it.

This makes the molecule massive and very water -soluble.

So it can't cross the blood -brain barrier.

It can't get into the brain, exactly.

It stays in the blood and in the gut.

So it can go to the intestine and block the opioid receptors there, which relieves the constipation.

But it can't get to the brain to block the pain relief.

So you get rid of the side effect without getting rid of the desired effect.

It's a magic bullet for opioid -induced constipation, especially in palliative care patients.

We are in the homestretch.

Section 9, clinical treatment of pain.

How do we synthesize all of this information into a coherent strategy?

The text outlines the strategy for acute versus chronic pain.

For acute pain -think post -surgical trauma,

the rule is start low, go slow, but don't be afraid to treat the pain adequately.

The text suggests dosing on a fixed schedule initially, not waiting for the patient to ask.

Why a fixed schedule instead of as needed, or PRM?

If you're always waiting for the pain to get bad before you treat it, you're always chasing it, you're always behind.

By giving it around the clock for the first 24 -48 hours, you stay ahead of the pain, you keep it controlled.

PCA pumps, patient -controlled analgesia, are great here because they give the patient control, which reduces anxiety.

But for chronic pain, the philosophy shifts completely.

For chronic non -cancer pain, opioids are generally a last resort.

We rely heavily on what the book calls co -analgesics, or adjuvants.

We already mentioned the antidepressants that boost the descending pathway.

What else is in the toolbox?

Antiepileptics.

Drugs like gabapentin or pregobolin.

These work by blocking calcium channels on overactive nerves.

They are the drug of choice for that shooting or electric zinging neuropathic pain.

And topical treatments.

There's one that's kind of counterintuitive.

Capsaicin.

It's the active ingredient in chili peppers.

It works by initially stimulating the release of all the substance P from the nerve endings, which causes a burning sensation.

So it makes it hurt more at first?

It does.

But with repeated use, it completely depletes the nerve terminals of substance P.

The nerve essentially runs out of ammunition and stops being able to send pain signals.

And finally, a very different situation.

Cancer pain.

Here, the rulebook changes completely.

In terminal cancer pain, we do not worry about addiction.

We do not worry about tolerance.

The primary goal is comfort and quality of life.

You use the WHO analgesic ladder.

You titrate the dose to effect, and you treat the side effects aggressively.

There is no maximum or ceiling dose for morphine in a dying cancer patient.

That's a powerful and important place to land.

We've gone from the molecular vibration of a single receptor all the way to the bedside philosophy of end -of -life care.

It's a whole spectrum.

And if you understand the molecules, you can manage the bedside so much better.

Before we sign off, I think we owe the listeners a quick check -in.

Let's do the pop quiz from the end of the chapter.

Test our own retention.

All right, let's do it.

I'll quiz you.

Question one.

Most clinically used opioid analgesics are selective for which type of receptor?

It's got to be the moo receptor, the celebrity with all the baggage.

Question two.

Why does codeine have greater oral bioavailability compared to morphine?

Oh, right, because of that methyl group.

It protects it from that heavy first -pass metabolism in the liver.

Morphine gets chewed up.

Codeine survives the pass much better.

Spot on.

Question three.

Why is morphine more likely to cause nausea in ambulatory patients, people walking around, than in patients who are on bed rest?

Because the nausea isn't just chemical, it's destipular.

Opioids sensitize the inner ear balance system, so moving around triggers the vertigo and vomiting.

Exactly.

Question four.

Which opioid is so lipophilic, so fat -loving, that it can be marketed in a skin patch?

That's fentanyl.

And for the win, question five.

In an opioid overdose, why might naloxone need to be given in repeated doses?

Because the half -life of naloxone is much shorter than the half -life of most of the opioid agonists.

The antidote wears off before the poison does.

You have to keep dosing.

You passed the boards.

Hell take it.

This has been a marathon session, but you know, absolutely necessary.

Chapter 23 is just foundational.

It is.

Understanding this pharmacology allows us to wield these incredibly powerful tools safely and effectively.

It's the difference between relief and tragedy.

Thank you so much for guiding us through the heavy science.

This has been a production of the Last Minute Lecture Team.

We really hope this helps you crush that exam or just be a better, safer clinician.

Study hard and stay curious.

See you on the next Deep Dive.